SCHEMBL2035403

SCHEMBL2035403

CON(C)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
MAPT P10636 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
MAPK1 P28482 1/20 0.54
TSHR P16473 4/20 0.53
LMNA P02545 1/20 0.53
ACHE P22303 1/20 0.50
NPC1 O15118 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
CHRNB2 P17787 1/20 0.48
CHRNA4 P43681 1/20 0.48
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
ALOX15 P16050 1/20 0.46
PYCR1 P32322 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28933703 0.84 TSHR (0.55) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL30780918 0.82 TSHR (0.61) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL1413129 0.82 TSHR (0.61) ALDH1A1MAPTMEN1KMT2AMAPK1
Bromide SCHEMBL28377987 0.80 TSHR (0.50) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL11819373 0.79 TSHR (0.57) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL14397069 0.79 TSHR (0.57) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL8977870 0.78 MAPT (0.53) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL12048735 0.77 ABCG2 (0.59) ALDH1A1MAPTMEN1KMT2AMAPK1
Dinitrophenylene SCHEMBL27263366 0.77 TSHR (0.81) ALDH1A1KMT2ATSHRLMNAACHE
SCHEMBL10651901 0.76 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2327677-A1 Mono-nitration of aromatic compounds F. Hoffmann-La Roche AG (CH) 2011-06-01 EP disclosed
EP-2016034-A2 MONO-NITRATION OF AROMATIC COMPOUNDS F. Hoffmann-Roche AG (CH) 2009-01-21 EP disclosed
US-7429589-B2 Mono-nitration of aromatic compounds via nitrate salts HOFFMANN-LA ROCHE INC. (US) 2008-09-30 US disclosed
WO-2007125034-A2 MONO-NITRATION OF AROMATIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2007-11-08 WO disclosed
US-20070255057-A1 Mono-nitration of aromatic compounds via nitrate salts CEDILOTE MIALL 2007-11-01 US disclosed
US-3931215-A OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255057-A1 Mono-nitration of aromatic compounds via nitrate salts NOS2, NOS3, NOS1 ALDH1A1 722/4885MAPT 1554/4885MEN1 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.